| 发明名称 |
INTERFERON FOR TREATMENT OF MULTIPLE SCLEROSIS |
| 摘要 |
This invention relates to nucleic acids and polypeptide sequences, which code for an interferon-beta-2 ("IFN- beta 2"). A pharmaceutical composition, which comprises a pharmaceutically acceptable excipient and a therapeutically effective amount of a human IFN- beta 2 polypeptide, biologically-active fragment thereof, or biologically-active derivative thereof, is useful in treating multiple sclerosis in humans. |
| 申请公布号 |
WO0195929(A3) |
申请公布日期 |
2002.10.10 |
| 申请号 |
WO2001US41022 |
申请日期 |
2001.06.18 |
| 申请人 |
SCHERING AKTIENGESELLSCHAFT;CROZE, EDWARD, M.;FAULDS, DARYL;WAGNER, T., CHARIS |
发明人 |
CROZE, EDWARD, M.;FAULDS, DARYL;WAGNER, T., CHARIS |
| 分类号 |
A61K38/00;A61K38/21;A61P19/02;A61P25/00;A61P25/28;A61P29/00;A61P31/12;A61P35/00;A61P37/02;A61P43/00;C07K14/555;C07K14/565 |
主分类号 |
A61K38/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
